Breast cancer

27 January 2011

Breast implants may be linked to rare cancer

Safety concerns have dogged breast implants for years and now US regulators have warned that women with implants may face an increased risk of a rare immune-system cancer.


Women with breast implants may face an increased risk of a rare immune-system cancer near their implants, US regulators said.

Health officials need more data to tell if the implants are related to the cancer and are asking doctors to report any confirmed cases, the Food and Drug Administration said in a statement. Overall the agency still considers implants safe.

Safety concerns have dogged breast implants for years. Silicone breast implants were banned for most US women in 1992 after some complained the devices leaked and made them chronically ill. Widespread sales resumed in 2006 with FDA approval over sharp protests from consumer advocates.

Are breast implants safe?

"This is exactly the kind of problem we were concerned about when we said we don't know enough about these products and whether they are safe," said Amy Allina, policy director at the National Women's Health Network.

The FDA said its review found about 60 cases of anaplastic large cell lymphoma (ALCL). The number is tough to verify and some reports could be duplicates, the agency said. Data so far suggest women with silicone or saline-gel breast implants "may have a very small but significant risk of ALCL in the scar capsule adjacent to the implant," the agency said.

"We need more data and are asking that healthcare professionals tell us about any confirmed cases they identify," said Dr William Maisel, chief scientist in the FDA's device unit.

An estimated 5 million to 10 million women around the world have breast implants.(Reuters Health/ January 2011)

FDA rules against silicone
Silicone breasts back in US
The silicone debate continues
Silicone implants prone to rupture 


Read Health24’s Comments Policy

Comment on this story
Comments have been closed for this article.

Ask the Expert

Breast cancer expert

Dr Gudgeon qualified in Birmingham, England, in 1968. She has more than 40 years experience in oncology, and in 1994 she founded her practice, Cape Breast Care, where she treats benign and malignant breast cancers. Dr Boeddinghaus obtained her qualification at UCT Medical School in 1994 and her MRCP in London in 1998. She has worked extensively in the field of oncology and has a special interest in the hormonal management of breast cancer. She now works with Dr Gudgeon at Cape Breast Care. Read more.

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules